Altimmune, Inc.
Coronavirus immunogenic compositions and uses thereof

Last updated:

Abstract:

Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.

Status:
Grant
Type:

Utility

Filling date:

9 Jun 2021

Issue date:

12 Jul 2022